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Abstract : Background : Gastric carcinomas have been classified into the differentiated
and undifferentiated type, on the basis of its tendency to gland formation. As a result of
recent advances in mucin histochemistry, mucin phenotypes of gastric carcinomas have
been investigated. However, no consensus on the evaluation of the grade of malignancy of
early gastric carcinomas regarding mucin phenotype expression has developed. To address
this issue, we evaluated the lymph node metastasis rate and proliferative activity of a
submucosal invasive (sm) gastric carcinoma according to mucin phenotype expression.
Methods : In resected surgical specimens from 108 patients with a single sm gastric car-
cinoma, the association between clinicopathological factors and lymph node metastasis
was evaluated. In all cases, immunohistochemical staining with human gastric mucin,
Muc-2, and CD10 and mucin histochemical staining by paradoxical concanavalin A stain-
ing were performed. The mucin phenotypes were classified into gastric-type (G-type),
intestinal-type (I-type), mixed gastric and intestinal type (M-type), or a lack of mucin
(LOM), using these as markers. To evaluate the cell proliferative activity of the gastric car-
cinoma, proliferating cell nuclear antigen (PCNA) staining was also performed.
Results : The rate of lymph node metastasis was higher for G-type sm carcinomas. A multi-
variate analysis showed that the G-type and lymphatic invasion were independent fac-
tors of lymph node metastasis. However, the PCNA-labeling index (PCNA-LI) was low
for G-type carcinomas irrespective of the presence or absence of lymph node metastasis.
In I-type carcinomas, PCNA-LI was significantly higher in cases that were positive for
lymph node metastasis than in negative cases.
Conclusion : G-type and lymphatic invasion are independent risk factors for lymph node
metastasis of an sm gastric carcinoma, and proliferative activity may be a significant pa-
rameter for lymph node metastasis in cases with I-type carcinomas. J. Med. Invest. 54 :
99-108, February, 2007
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INTRODUCTION
Due to recent improvements in diagnostic tech-
niques, the early detection of gastric carcinomas has
been increasing(1-3), and submucosal invasive (sm)
gastric carcinomas have frequently been encoun-
tered. However, lymph node metastasis is observed
in 10-25% of patients with sm gastric carcinomas as
early stage carcinomas, and previous studies have
shown that endoscopic treatment alone is not ade-
quate in such patients(4-9). On the other hand, it
has been reported that the presence or absence of
lymph node metastasis can be estimated, even in
patients with sm gastric carcinomas based on his-
tology and the depth of submucosal invasion, and
endoscopic treatment is indicated in some of these
patients(8, 9). In sm gastric carcinoma, the pres-
ence of lymph node metastasis is seemed to affect
not only survival after surgical or endoscopic treat-
ment, but also decision of the therapy. Therefore,
establishment of supplementary diagnosis of lymph
node metastasis is very important.
The histology of gastric carcinomas is convention-
ally classified into differentiated and undifferentiated
types. The former had been regarded as intestinal-
type (I-type) carcinomas closely associated with in-
testinal metaplasia, and the latter as gastric-type (G-
type) carcinomas developing in the gastric mucosa
(10, 11). However, due to advances in mucin histo-
chemistry, the mucin phenotypes of gastric carci-
noma have been investigated, and a high incidence
of the G-type in differentiated-type carcinomas has
been verified, and studies have extensively evalu-
ated the histogenesis of gastric carcinomas(12-23).
Many authors have reported that G-type carcinomas
have various clinicopathological characteristics that
differ from those of I-type carcinomas(14, 18, 20, 23,
24). However, the rate of lymph node metastasis
according to mucin phenotype or the grade of ma-
lignancy such as cell proliferative activity of early
stage gastric carcinomas has not been adequately
evaluated. Therefore, to clarify the association be-
tween the mucin phenotypes of gastric carcinomas
and the rate of lymph node metastasis or cell pro-
liferative activity, we investigated mucin phenotypes
by mucin histochemical and immunohistochemi-
cal techniques in cases of sm gastric carcinomas
and evaluated their association with the rate of lymph
node metastasis and cell proliferative activity.
MATERIALS AND METHODS
Subjects
This study included 108 consecutive cases of sin-
gle sm gastric carcinomas (79 differentiated- and 29
undifferentiated-type carcinomas) in which surgical
resection and lymph node dissection had been per-
formed between 1986 and 1996, and in which the re-
sected specimens showed adequate remnants of the
carcinoma nest in the mucosa. Using the resected
specimens from these cases, the association between
clinicopathological items (location, macroscopic type,
histology, depth of submucosal invasion, venous in-
vasion, and lymphatic invasion) and lymph node me-
tastasis was evaluated. The gastric carcinomas were
histologically classified according to Nakamura’s
Classification(10) based on the extent of glandular
formation into differentiated and undifferentiated
types. A detailed histological classification was per-
formed according to the General Rules for the Gas-
tric Cancer Study(25). To classify the depth of carci-
noma invasion into the submucosal layer, the sub-
mucosal layer was divided into 3 equal portions, and
tumors with their deepest site being in the superficial
layer of the submucosal layer were defined as sm1
carcinomas, those with the deepest site close to the
propria muscularis as sm3 carcinomas, and those
located intermediate between sm1 and sm3 were
defined as sm2 carcinomas.
Mucin histochemical and immunohistochemical
stainings
The gastrectomy specimens were fixed in 10%
buffered formalin for 24-120 hours, cut into 5-mm
sections, and embedded in paraffin. Pathological
observation was performed by routine hematoxylin/
eosin (HE) staining, and sections at the deepest site
of the submucosal tumor invasion were selected
for microscopic examination. Thin sections (3 μm)
at the deepest site of the tumor were prepared us-
ing slide glasses coated with poly-L-lysine for stain-
ing. The primary antibodies used in the immuno-
histochemical staining were a Human Gastric Mucin
mouse monoclonal antibody (NCL-HGM-45M1 clone
45M1, Novocastra ; UK, 1 : 50) as a marker for G-
type, a Muc-2 Glycoprotein mouse monoclonal an-
tibody (NCL-MUC-2 clone Ccp58, Novocastra ; UK,
1 : 100) and a CD10 mouse monoclonal antibody
(NCL-CD10-270 clone 56C6, Novocastra ; UK, 1 :
80) as markers for I-type, and a proliferating cell
nuclear antigen (PCNA) mouse monoclonal anti-
body (NCL-PCNA clone PC19, Novocastra ; UK,
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1 : 100) as a marker for proliferative cells. For Muc-
2 and CD10, for antigen enhancement, paraffin-
embedded sections were deparaffinized, immersed
in 0.01 M citrate buffer (pH, 6.0), and subjected to
microwave irradiation (750 W) for 4 times for 5
minutes each, according to the method of Shi, et al.
(26). Staining was performed by the labeled strep-
tavidin biotin method using an LSAB kit (DAKO ;
USA). As the primary antibodies, HGM, Muc-2, and
CD10 were incubated at 25℃ for 60 minutes, and
PCNA was incubated at 4℃ for 18 hours. After col-
oring with a 0.02% 3,3’-diaminobenzidine (DAB) so-
lution (pH, 7.6), nuclear staining was performed with
Mayer’s hematoxylin. In addition, class III mucin
was stained with Concanavalin A (Con A) (type IV,
Sigma Chemical ; St. Louis, 1 : 1,000) by the method
of Katsuyama and Spicer(27). Oxidation was per-
formed by treatment with 1% periodic acid (PA) for
60 minutes, and the immersion time in the Con A so-
lution was 60 minutes. Coloring and nuclear staining
were performed by a method similar to the above.
The Human gastric mucin antibody is specific for
gastric foveolar cells and has a stable stainability(28).
Paradoxical Con A staining is useful for the identifi-
cation of pyloric gland-type mucin(27, 29, 30). The
Muc-2 glycoprotein recognizes mucous core protein
specific to goblet cells(31-33). CD10, also known
as common acute lymphocytic leukemia antigen
(CALLA), is also positive for the intestinal brush
border and is useful for the identification of I-type(34,
35). Proliferating cell nuclear antigen (PCNA) is use-
ful for the identification of cells in the proliferative
phase(36). The PCNA expression rate can be a po-
tential prognostic marker in human malignancy(37).
Determination of the mucin phenotype and PCNA-
labeling index
For the identification of the G-type, only mucus
of the cytoplasm of carcinoma cells was evaluated.
The mucin phenotype is regarded as G-type when
more than 5% of the entire carcinoma mucosal area
is stained with G-type markers (HGM or Con A),
and is regarded as I-type when 5% of the entire car-
cinoma is stained by I-type markers (Muc-2 or CD
10). For CD10, only cell membrane stainability was
evaluated because the brush border of absorptive
intestinal enterocytes is stained. When both the G-
type and I-type were expressed, the phenotype was
defined as the mixed gastric and intestinal type (M-
type). The absence of expression of either G-type
or I-type was regarded as a lack of mucin (LOM)
(Table 1). In PCNA immunostaining, more than
Table 1. Immunohistochemistry and mucin histochemistry for the classification of gastric and intestinal mucin phenotypes
Immunohistochemistry
Antibody Clone Mucin histochemistry Specificity
Gastric type markers
HGM 45M1 ― Peptide core of human gastric mucin
― ― PCS (Class III) Pyloric gland type mucin
Intestinal type markers
Muc-2 Ccp58 ― Muc-2 glycoprotein
CD 10 56C6 ― Brush border on luminal surface
HGM : human gastric mucin ; PCS : paradoxical concanavalin A staining
Table 2. Relationship between clinicopathological factors and lymph node metastasis associated with 108 gastric carcinomas with
submucosal invasion
Characteristic Value Lymph node
metastasis(%)
P value
Age (yrs) : Mean ± SD (range) 62.7 ± 9.5 (35-82) ― ―
Gender (Male : Female) 78 : 30 7.7 : 16.7 NS
Location (U : M : L) 18 : 53 : 37 0 : 13.2 : 10.8 NS
Macroscopic type (elevated : depressed : mixeda) 13 : 73 : 22 7.7 : 11.0 : 9.1 NS
Size (cm) : Mean ± SD (range) 3.4 ± 1.9 (0.6-9.8) ― ―
Histology (differentiated : undifferentiated type) 79 : 29 8.9 : 13.8 NS
Depth of submucosal invasion (sm 1 : sm 2 : sm 3) 22 : 46 : 40 13.6 : 4.3 : 15.0 NS
Venous invasion (negative : positive) 101 : 7 7.9 : 42.9 <0.01
Lymphatic invasion (negative : positive) 84 : 24 3.6 : 33.3 <0.001
U, M, L : upper, middle, and lower one-thirds of the stomach, respectively. SD : standard deviation
a mixed type consists of both of elevated and depressed components.
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500 carcinoma cells in areas showing relatively uni-
form stainability at the invasive front were observed
by microscopy, and cells in which the nucleus was
stained were considered to be positive. Those, which
did not show adequate stainability in the prolifera-
tive zone of the non-carcinoma portion of the tis-
sue section, were excluded from evaluation. Positive
cells were expressed in terms of percentages as the
PCNA-labeling index (PCNA-LI).
Statistical analysis
Lymph node metastasis rate was analyzed by
the χ2 test and Fisher’s exact probability method,
and PCNA-LI was analyzed by the unpaired t-test and
ANOVA with Stat View software. A multivariate
analysis by logistic regression was also performed
with SAS software. The odds ratios were presented
with a 95% confidence interval by multivariate analy-
sis. P < 0.05 was considered to be significant.
RESULTS
Clinicopathological factors and the lymph node
metastasis rate
Of the 108 cases of sm gastric carcinomas, 11
(10.2%) were positive for lymph node metastasis.
Table 2 summarizes the association between clini-
copathological factors for sm gastric carcinomas and
lymph node metastasis. Venous invasion and lym-
phatic invasion were associated with lymph node
metastasis. The lymph node metastasis rate was
8.9% (7/79) for differentiated-type gastric carcinomas
and 13.8% (4/29) for undifferentiated-type gastric
carcinomas, with no significant difference. The rate
of lymph node metastasis as a function of the depth
of sm invasion was 13.6% for sm 1, 4.3% for sm2,
and 15.0% for sm3, being high even for sm1 and sug-
gesting no association between the depth of sm in-
vasion and the rate of lymph node metastasis. The
rate of lymph node metastasis was also not associ-
ated with sex, location, or macroscopic type.
The incidence of expression of each mucin pheno-
type and its association with the lymph node me-
tastasis rate
Figs. 1 A～D and 2 A～C show typical cases that
were found to be positive for G-type and I-type mucin
histochemical staining and immunohistochemical
staining. Table 3 summarizes the incidences of mu-
cin phenotypes and rates of lymph node metastasis,
as evidenced by histology. In the differentiated-type
Fig. 1. Expression of gastric type mucin
Carcinoma cells are positive for human gastric mucin (45M-1). (A) differentiated type carcinoma (× 50) (B) undifferentiated type car-
cinoma (× 50)
ConA III staining is partially positive in the carcinoma. (C) differentiated type carcinoma (× 100) (D) undifferentiated type carci-
noma (× 50)
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gastric carcinomas, the I-type was the most fre-
quently observed (39.2%, 31/79), followed by the
M-type (31.6%, 25/79), LOM (15.2%, 12/79), and G-
type (13.9%, 11/79). In the undifferentiated gastric
carcinomas, the G-type was most frequently observed
(41.4%, 12/29), followed by the M-type (34.5%, 10/
29), LOM (13.8%, 4/29), and I-type (10.3%, 3/29).
The rate of lymph node metastasis according to mu-
cin phenotype was higher for the G-type (26.1%, 6/
23) than for the I-type (5.9%, 2/34) or the M-type
(2.9%, 1/35), and a significant difference was rec-
ognized between G-type and M-type (p < 0.05). This
tendency was also observed in a separate evaluation
of differentiated and undifferentiated carcinomas.
Multivariate analysis of lymph node metastasis
Based on the above results on the lymph node
metastasis rate, we established a hypothesis that
lymphatic invasion, venous invasion, and the mu-
cin phenotype are important variables as factors as-
Table 3. Relationship between mucin phenotype and lymph node metastasis
Histological type
Mucin phenotype Differentiated Undifferentiated Total
G-type 3 / 11 (27.3)a 3 / 12 (25.0) 6 / 23 (26.1)c
I-type 2 / 31 (6.5) 0 / 3 (0) 2 / 34 (5.9)
M-type 0 / 25 (0)b 1 / 10 (10.0) 1 / 35 (2.9)d
LOM 2 / 12 (6.7) 0 / 4 (0) 2 / 16 (12.5)
Total 7 / 79 (8.9) 4 / 29 (13.8) 11 / 108 (10.2)
( ) : %
a vs b, c vs d : p<0.05
Fig. 2. Immunohisitochemical expression of intestinal typemucin
(A) Differentiated type adenocarcinoma, expression of goblet
cell type mucin by Muc-2 glycoprotein (× 25)
(B) Muc-2 positive cells are scattered in the undifferentiated
type carcinoma. (× 100)
(C) CD 10 is strongly positive along the luminal surface of the
glands in the well differentiated adenocarcinoma. (× 50)
Table 4. Multivariate logistic regression analysis of lymph node metastasis
Characteristic Odds ratio 95% CI P value
G-type 5.128 0.552 - 47.656 0.151
I-type 0.565 0.048 - 6.648 0.650
M-type 0.221 0.013 - 3.869 0.302
Venous invasion 9.266 0.894 - 96.081 0.062
Lymphatic invasion 12.942 2.481 - 67.502 0.002
95% CI : 95% confidence interval
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sociated with lymph node metastasis. To confirm this
hypothesis, multivariate analysis using a logistic
model was performed. The results of analysis us-
ing 5 variables first selected (lymphatic invasion,
venous invasion, G-type, I-type, and M-type) are
shown in Table 4. Subsequently, variable selection
by the backward elimination procedure was per-
formed, and two variables (lymphatic invasion and
G-type) remained as significant variables in the final
model (Lymphatic invasion : odds ratio, 16.846 ; 95%
confidence interval, 3.454-82.171 ; p < 0.001 G-type :
odds ratio, 7.690 ; 95% confidence interval, 1.609-
36.748 ; p = 0.011).
Clinicopathological factors and PCNA-LI
To evaluate proliferative activity, PCNA staining
was performed in all 108 cases. As a result, only 53
of 108 cases could be immunohistochemically evalu-
ated in the point of their stainability. It was consid-
ered that PCNA immunoreactivity possibly had been
greatly reduced or abolished because the time of
fixation in formalin solution was too long in many
cases(36). The association between the clinicopa-
thological factors and PCNA-LI in 53 cases in which
it was possible to immunohistochemically evaluate is
shown in Table 5. PCNA-LI was significantly higher
(p < 0.05) in cases that were positive for lymph node
metastasis (43.4 ± 27.4%) than in negative cases
(27.7 ± 19.0%). PCNA-LI according to the depth of
sm invasion was significantly higher for sm3 (45.1
± 24.3%) than for sm1 (21.3 ± 15.0%) or sm2 (25.5
± 17.5%), and that according to histology was sig-
nificantly higher (p < 0.01) for papillary adenocar-
cinomas (58.8 ± 26.2%) than for the other histo-
logical types. PCNA-LI according to mucin pheno-
type did not significantly differ among I-type (36.2
± 24.0%), M-type (27.1 ± 21.4%), LOM (41.9 ±
23.2%), and G-type (22.7 ± 15.1%) but was the low-
Table 5. Relationship between clinicopathological factors and PCNA-LI
Clinicopathological
factors
Number
of cases
PCNA-LI, %
Mean ±SD P value
Lymph node metastasis
+ 11 43.4 ±27.4 <0.05
－ 42 27.7 ±19.0
Submucosal invasion
sm1 15 21.3 ±15.0 a
sm2 20 25.5 ±17.5 b <0.01 (c vs a,b)
sm3 18 45.1 ±24.3 c
Histological type
pap 7 58.8 ±26.2 d
well 14 25.8 ±14.4 e
moderate 12 28.0 ±24.2 f <0.01 (d vs e,f,g,h)
por 8 25.9 ±17.1 g
sig 12 27.2 ±16.3 h
Mucin phenotype
G-type 12 22.7 ±15.1
I-type 12 36.2 ±24.0 NS
M-type 19 27.1 ±21.4
LOM 10 41.9 ±23.2
Lymphatic invasion
+ 24 36.4 ±23.1 NS
－ 29 26.4 ±19.8
Venous invasion
+ 5 40.6 ±33.9 NS
－ 48 30.0 ±20.3
pap : papillary adenocarcinoma ; well : well differentiated adenocarcinoma ; moderate : moderately differentiated adenocarcinoma
por : poorly differentiated adenocarcinoma ; sig : signet ring cell carcinoma
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est for G-type. PCNA-LI according to mucin phe-
notype in the presence or absence of lymph node
metastasis was evaluated. In cases positive for lymph
node metastasis, PCNA-LI for the G-type (23.5 ±
15.0%) was significantly lower (p < 0.05) than that
for the I-type (75.2 ± 18.8%) or LOM (64.7 ± 23.3%).
PCNA-LI for the G-type was similar between cases
that were positive (23.5 ± 15.0%) and those that were
negative (21.9 ± 16.7%) for lymph node metasta-
sis, while that for the I-type was significantly higher
in cases positive for lymph node metastasis (75.2 ±
18.8%) and negative cases (28.4 ± 16.0%) (Table 6).
Fig. 3 A, B shows Muc-2 and PCNA staining mi-
crographs in the case of an I-type differentiated ade-
nocarcinoma that was positive for lymph node me-
tastasis.
DISCUSSION
Due to recent advances in mucin histochemical
techniques, a considerable number of differentiated-
type carcinomas showing G-type and undifferenti-
ated carcinomas showing I-type have been reported
(12, 14, 17-23). In this study, according to the mucin
phenotypes, the incidence of G-type was 13.9% (11/
79) in differentiated-type adenocarcinomas, and that
of the I-type was 10.3% (3/29) in undifferentiated-
type adenocarcinomas. As previously reported(14,
20, 23, 38), there is no consistency between mucin
phenotype expression and histological type.
The rate of lymph node metastasis for sm G-type
carcinomas was 26.1%, clearly higher than that for
the other mucin phenotypes, suggesting its high
grade of malignancy. A multivariate analysis showed
that the G-type is an independent factor associated
with lymph node metastasis. Noda(38) analyzed
18 cases of early gastric carcinomas showing lymph
node metastasis and observed a high incidence of
G-type (15/18, 84%). Oya, et al.(39) identified the
mucin phenotype in 47 cases of early gastric carci-
nomas that were positive for lymph node metasta-
sis and 91 not showing lymph node metastasis, and
suggested that early gastric carcinomas showing the
G-type in an early stage are biologically aggressive.
Koseki, et al.(24) evaluated cases of differentiated
sm gastric carcinomas and observed a high rate of
lymph node metastasis for G-type sm carcinomas
(11/29, 37.9%) and the highest correlation between
lymph node metastasis and the G-type. The results
of this study support their findings.
Kushima, et al.(18) examined 1-2 cm diameter
intramucosal carcinomas and reported that only 30%
of the gastric differentiated adenocarcinomas were I-
type from the initial stage, and most were the G-type
or M-type. Tatematsu, et al.(17) compared mucin
phenotype expression between m carcinomas and
carcinomas showing sm or deeper invasion and
observed a significantly higher incidence of the I-
type in the latter. Egashira, et al. , who studied dif-
ferentiated gastric microcarcinomas (< 5 mm), also
observed the G-type in 41.1% and the addition of
the I-type with an increase in tumor diameter(21).
Fig. 3. Moderately differentiated adenocarcinoma with lymph
node metastasis, intestinal type
(A) Carcinoma cells are positive for Muc-2. (× 25)
(B) PCNA-positive cells were clearly identified in the invasive front
of the cancer, as evidenced by brown nuclear staining. PCNA-LI
is 61.9%. (× 50)
Table 6. Relationship between mucin phenotype and PCNA-
LI associated with lymph node metastasis
Lymph node metastasis
Mucin phenotype + ‐ Total
G-type 23.5 ±15.0a(n=6) 21.9 ±16.7(n= 6) 22.7 ±15.1 (n=12)
I-type 75.2 ±18.8b(n=2) 28.4 ±16.0d(n=10) 36.2 ±24.0 (n=12)
M-type 56.7(n=1) 25.5 ±20.7(n=18) 27.1 ±21.4 (n=19)
LOM 64.7 ±23.3c(n=2) 36.3 ±20.7(n= 8) 41.9 ±23.2 (n=10)
a vs b : p<0.01 ; a vs c : p<0.05 ; b vs d : p<0.01
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On the other hand, in undifferentiated-type carci-
nomas, changes in the mucin phenotype have also
been reported. Various studies have shown com-
plete preservation of the G-type in the early stage
of signet ring cell carcinomas but acquisition of
the I-type in the process of progression(13, 16, 19).
Thus, it has been gradually clarified that the mu-
cin phenotype can change during the process of
progression. Considering these changes, lymph node
metastasis may tend to develop in cases showing
the G-type from the initial stage and preservation
of the G-type without changes in the mucin pheno-
type, even after sm invasion.
To clarify the reason for the high incidence of
lymph node metastasis in G-type carcinomas, we
used PCNA-LI as a parameter for proliferative ac-
tivity. PCNA-LI was significantly higher in cases that
were positive for lymph node metastasis, showing
its usefulness for evaluating proliferative activity.
However, despite the high rate of lymph node
metastasis for G-type sm gastric carcinomas, their
proliferative activity was generally and unexpect-
edly low. These results suggest that proliferative
activity may not be a parameter of lymph node
metastasis in G-type sm gastric carcinomas. In G-
type carcinomas, even when the proliferative activ-
ity is low, lymph node metastasis can occur. In the
G-type, no difference in carcinoma cell proliferative
activity was found between metastasis-positive and -
negative cases. In contrast, in the case of the I-type,
proliferative activity significantly differed between
metastasis-positive and-negative cases. Kushima, et
al.(18) examined gastric intramucosal carcinomas
and reported that the number of PCNA-positive cells
tended to be lower in G-type adenocarcinomas than
in other-type adenocarcinomas. They speculated
that this is because many cancer cells in G-type ade-
nocarcinomas contain foveolar-epithelium-type or
pyloric-gland -type mucin and have lost the ability to
proliferate, or that they have mimicked the differen-
tiation mode of normal cells in the gastric proper
mucosa, and most cancer cells drop out of the cell
cycle and differentiate and mature into cells that
resemble surface mucous cells and pyloric gland
cells. Saito, et al.(22) reported in their study of early
gastric carcinomas that differentiated adenocarci-
nomas with the G-type histologically transform into
undifferentiated-type adenocarcinomas with an in-
crease in tumor size. Certain factors other than pro-
liferative activity may be involved in the lymph node
metastasis of G-type sm gastric carcinomas. Such
factors were not clarified in this study. However, we
speculate that G-type sm gastric carcinomas, de-
spite their low proliferative activity, transform into
the undifferentiated type with the progression of
invasion, which facilitates carcinoma cell separa-
tion from the glands, leading to vascular invasion
and lymph node metastasis. In this study, in I-type
sm gastric carcinomas, proliferative activity was
significantly higher in cases that were positive for
lymph node metastasis than in negative cases, and
proliferative activity can be a parameter for lymph
node metastasis. Thus, it would be of interest to
determine if the incidence of lymph node metastasis
and proliferative behavior differed among mucin
phenotypes.
In conclusion, G-type expression in sm carcino-
mas may be an important risk factor for lymph node
metastasis, and attention should be paid to G-type
carcinomas even if they are clinically of the differ-
entiated type. Furthermore, it is seemed that pro-
liferative activity is a significant parameter for lymph
node metastasis in cases with I-type carcinomas.
Therefore, in addition to the conventional exami-
nation of histological type, a preoperative examina-
tion of the mucin phenotype may be an important
supplementary diagnosis.
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